Search Result
" Evusheld"

8 results

Business - Markets & Companies
2/23/2022 12:57:14 PM
Last week, The Egyptian Authority for Unified Procurement (UPA) inked a memorandum of understanding (MoU) with AstraZeneca in order to sponsor Egypt’s first ‘Africa Health ExCon’, which is scheduled for June.

Business - Markets & Companies
2/8/2022 6:07:08 PM
AstraZeneca’s Country President for Egypt Hatem Werdany spoke to Ahram Online about the Evusheld coronavirus treatment, its pricing policy, as well as the company’s other actions in the Egyptian market regarding providing jabs and how the company sees Egypt as a market for the pharmaceutical industry.

Egypt - Health
2/1/2022 11:28:20 AM
Egypt reported 2,223 COVID-19 infections on Monday, a slight increase in cases over Sunday's figures, setting another record high for the seventh day in a row, as the country continues to battle the pandemic.

Egypt - Health
1/31/2022 5:58:52 PM
The first batch of AstraZeneca’s Evusheld — a monoclonal antibody drug that resists the coronavirus — comprising 15,000 doses arrived in Egypt, the company announced on Monday.

Egypt - Health
1/16/2022 2:43:48 PM
AstraZeneca announced on Sunday that the Egyptian Drug Authority (EDA) has granted AstraZeneca’s ‘Evusheld’ an emergency use authorisation (EUA).

Egypt - Health
1/3/2022 11:20:00 PM
Egypt is expected to receive its first shipments of the Pfizer and AstraZeneca coronavirus drugs in January, Egyptian health ministry spokesman Hossam Abdel-Ghaffar said on Monday.

Egypt - Health
12/22/2021 5:24:50 PM
Presidential Adviser for Health Affairs Mohamed Awad Tag El-Din announced on Tuesday evening that Egypt may locally manufacture COVID-19 treatment pills developed by giant pharmaceutical company Merck in a matter of a month or so.

Egypt - Health
12/14/2021 4:53:00 PM
AstraZeneca has signed a procurement agreement with the Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management (UPA) for the recently authorized long-acting antibody (LAAB) combination, Evusheld, a statement by the company announced on Monday.